Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6417445 [patent_doc_number] => 20100167278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 12/341553 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5048 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167278.pdf [firstpage_image] =>[orig_patent_app_number] => 12341553 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/341553
Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer Dec 21, 2008 Abandoned
Array ( [id] => 6529059 [patent_doc_number] => 20100015166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Therapeutic antibodies' [patent_app_type] => utility [patent_app_number] => 12/316621 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7708 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015166.pdf [firstpage_image] =>[orig_patent_app_number] => 12316621 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/316621
Therapeutic antibodies Dec 14, 2008 Issued
Array ( [id] => 5586258 [patent_doc_number] => 20090105460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Antibody and inhibitor, and transfection method or kit using them' [patent_app_type] => utility [patent_app_number] => 12/314556 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9111 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105460.pdf [firstpage_image] =>[orig_patent_app_number] => 12314556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/314556
Antibody and inhibitor, and transfection method or kit using them Dec 11, 2008 Issued
Array ( [id] => 5464356 [patent_doc_number] => 20090324556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/314218 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7956 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324556.pdf [firstpage_image] =>[orig_patent_app_number] => 12314218 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/314218
Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof Dec 4, 2008 Issued
Array ( [id] => 5563566 [patent_doc_number] => 20090136418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Peptides specific for hepatocellular carcinoma cells and applications thereof' [patent_app_type] => utility [patent_app_number] => 12/292401 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15702 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136418.pdf [firstpage_image] =>[orig_patent_app_number] => 12292401 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/292401
Peptides specific for hepatocellular carcinoma cells and applications thereof Nov 17, 2008 Issued
Array ( [id] => 6070134 [patent_doc_number] => 20110044984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Monoclonal Antibody Capable of Binding to Anexelekto, and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/742947 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22296 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044984.pdf [firstpage_image] =>[orig_patent_app_number] => 12742947 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/742947
Monoclonal antibody capable of binding to anexelekto, and use thereof Nov 13, 2008 Issued
Array ( [id] => 5452067 [patent_doc_number] => 20090068104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use' [patent_app_type] => utility [patent_app_number] => 12/270110 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10156 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068104.pdf [firstpage_image] =>[orig_patent_app_number] => 12270110 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/270110
Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use Nov 12, 2008 Abandoned
Array ( [id] => 5508478 [patent_doc_number] => 20090081685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE' [patent_app_type] => utility [patent_app_number] => 12/268850 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13378 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081685.pdf [firstpage_image] =>[orig_patent_app_number] => 12268850 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/268850
METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE Nov 10, 2008 Abandoned
Array ( [id] => 6280473 [patent_doc_number] => 20100119527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY' [patent_app_type] => utility [patent_app_number] => 12/268302 [patent_app_country] => US [patent_app_date] => 2008-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21507 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119527.pdf [firstpage_image] =>[orig_patent_app_number] => 12268302 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/268302
N-cadherin: target for cancer diagnosis and therapy Nov 9, 2008 Issued
Array ( [id] => 5385196 [patent_doc_number] => 20090226441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/265154 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 43501 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226441.pdf [firstpage_image] =>[orig_patent_app_number] => 12265154 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/265154
ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE Nov 4, 2008 Abandoned
Array ( [id] => 6502416 [patent_doc_number] => 20100260667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease' [patent_app_type] => utility [patent_app_number] => 12/260892 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 50339 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260667.pdf [firstpage_image] =>[orig_patent_app_number] => 12260892 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/260892
Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease Oct 28, 2008 Abandoned
Array ( [id] => 5484930 [patent_doc_number] => 20090274695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Inhibition of urokinase-type plasminogen activator (uPA) activity' [patent_app_type] => utility [patent_app_number] => 12/290013 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 23862 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274695.pdf [firstpage_image] =>[orig_patent_app_number] => 12290013 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/290013
Inhibition of urokinase-type plasminogen activator (uPA) activity Oct 22, 2008 Abandoned
Array ( [id] => 5284958 [patent_doc_number] => 20090098633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells' [patent_app_type] => utility [patent_app_number] => 12/288547 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20905 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12288547 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/288547
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells Oct 19, 2008 Issued
Array ( [id] => 5564119 [patent_doc_number] => 20090136972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHODS FOR THE DIAGNOSIS OF GENITOURINARY CANCER' [patent_app_type] => utility [patent_app_number] => 12/253592 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16100 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136972.pdf [firstpage_image] =>[orig_patent_app_number] => 12253592 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/253592
Methods for the diagnosis of genitourinary cancer Oct 16, 2008 Issued
Array ( [id] => 6485802 [patent_doc_number] => 20100285474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/738062 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285474.pdf [firstpage_image] =>[orig_patent_app_number] => 12738062 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738062
Diagnostic, predictive and prognostic testing for cancer Oct 14, 2008 Issued
Array ( [id] => 4464961 [patent_doc_number] => 07935785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Selective substrates for matrix metalloproteinases' [patent_app_type] => utility [patent_app_number] => 12/252160 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24252 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935785.pdf [firstpage_image] =>[orig_patent_app_number] => 12252160 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/252160
Selective substrates for matrix metalloproteinases Oct 14, 2008 Issued
Array ( [id] => 6024267 [patent_doc_number] => 20110052593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'BREAST CANCER ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 12/738211 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10318 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052593.pdf [firstpage_image] =>[orig_patent_app_number] => 12738211 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738211
BREAST CANCER ASSOCIATED ANTIGEN Oct 14, 2008 Abandoned
Array ( [id] => 6622924 [patent_doc_number] => 20100311102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Electrophysiology Methods for Identification of Protein Structures in Membranes Associated to Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 12/682230 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6726 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311102.pdf [firstpage_image] =>[orig_patent_app_number] => 12682230 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682230
Real time electrophysiological testing of agents of interest for treatment of amyloid-type diseases Oct 8, 2008 Issued
Array ( [id] => 7534997 [patent_doc_number] => 08048621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/286291 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 50362 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048621.pdf [firstpage_image] =>[orig_patent_app_number] => 12286291 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/286291
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Sep 28, 2008 Issued
Array ( [id] => 5564090 [patent_doc_number] => 20090136943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'METHOD OF DETECTING CANCER USING DELTA-CATENIN' [patent_app_type] => utility [patent_app_number] => 12/238539 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136943.pdf [firstpage_image] =>[orig_patent_app_number] => 12238539 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/238539
Method of detecting cancer using delta-catenin Sep 25, 2008 Issued
Menu